HOME >> MEDICINE >> NEWS
Combining osteoporosis drugs produce no added benefit

Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.

The study disproved a previously untested but widespread belief among bone researchers that combining the two types of drugs -- bone-building parathyroid hormone (PTH) and bone resorption inhibiting bisphosphonates -- should interact in a beneficial way for patients. The combination is no better than either drug alone and may even reduce the bone-building benefit, according to study results.

Black presented the findings at the American Society for Bone and Mineral Research in Minneapolis on September 20. The study results are also reported in the September 25 issue of the New England Journal of Medicine.

The randomized, double-blind trial measured the bone density of 238 postmenopausal women for one year as they took one of three daily treatments. Participants in the multi-site study took either parathyroid hormone (PTH 1-84); the bisphosphonate alendronate, marketed as Fosamax; or both. All the women began the trial with low bone mineral density.

Parathyroid hormone in the form of PTH 1-34 has been available for treatment of severe osteoporosis since its FDA approval in 2002. This trial evaluated the full-length molecule PTH 1-84 that contains 50 additional amino acids. Despite a wide-spread belief among bone researchers that bisphosphonates and parathyroid hormone would interact in a synergistic way to compound the benefit for patients, no benefit was demonstrated. Rather, the findings suggest that the concurrent use of alendronate may reduce the bone-building, or anabolic, effects of parathyroid hormone.

"We're in the early stages of use for a whole new class of bone-building medications for osteoporosis," said UCSF Professor Dennis Black, PhD, principal investigator. "These anabolic agents offer an alternative, and, with decreased reliance on estrogen,
'"/>

Contact: Eve Harris
eharris@pubaff.ucsf.edu
415-885-7277
University of California - San Francisco
20-Sep-2003


Page: 1 2 3

Related medicine news :

1. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
2. Combining hormones with external, internal radiation helps high risk prostate cancer patients
3. Combining liver transplantation and coronary artery bypass grafting can be safe and effective
4. Combining surgery with novel treatment may improve survival rates
5. Combining medication, family counseling improves treatment outcome for men who abuse heroin
6. Combining osteoporosis treatments does not produce better results
7. Combining two types of radiation therapy better for treating brain cancer
8. Study Finds Combining Exercise With Male Hormone Therapy Benefits Men With HIV-Wasting Disease
9. History of broken bones overlooked when treating osteoporosis
10. Screening for osteoporosis prevents hip fractures in older adults
11. Calcium boost to youths bones could reduce osteoporosis risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... BOISE, Idaho (PRWEB) , ... December 10, 2018 , ... Five years ago, Erica Lester ... married to a darling man who loved me to pieces. I had two beautiful daughters. ... But inside, I was miserable.” , Lester says she spent most days struggling to ...
(Date:12/8/2018)... ... December 07, 2018 , ... “The ... juncture in world affairs, U.S. leadership and funding at the United Nations matters. ... strides in reducing extreme poverty and advancing global health plus meaningful reforms in ...
(Date:12/6/2018)... ... December 06, 2018 , ... We all know ... are alternative solutions. M.D.-formulated Relaxium Calm is a dietary supplement developed to promote ... Sensoril®, an extract of the ashwagandha root. Ashwagandha is a powerful herb that ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... of the first plastic surgery practices in Houston to offer the BodyTitePRO treatment. ... his patients an innovative range of surgical and noninvasive techniques to improve the ...
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced ... Consulting services, announced its new office location in Paris, France during the Partnerships ... clinical trial operations in Europe and additional in-country personnel. , “The new office ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... Fla. (PRWEB) , ... November 29, 2018 , ... ... practitioner-channel dietary supplement company – announced today the launch of the Annatto-E™ product ... annatto plant (Bixa orellana). Backed by clinical research, DFH’s new Annatto-E™ products are ...
(Date:11/29/2018)... , ... November 29, 2018 , ... ... This unique product makes the company’s powerful electronic forms and eSignatures functionality accessible ... progress by leaps and bounds in the consumer space and it’s about time ...
(Date:11/28/2018)... Israel (PRWEB) , ... November 28, 2018 , ... ... is traveling to Israel’s Sheba Medical Center, Tel HaShomer this week to form ... hospital in his home country, the Democratic Republic of Congo. , On ...
Breaking Medicine Technology:
Cached News: